mits, "A recent CDC survey from 10 states parti
Post# of 9144
(Total Views: 561)
Posted On: 08/29/2020 11:38:25 AM
Re: mitstevfel #7177
mits,
"A recent CDC survey from 10 states participating in the Active Bacterial Core Surveillance demonstrated that, although use of NAAT-based assays for GBS screening has increased since the last perinatal guidelines were published in 2010, reported use overall remained low in 2016. With more than 93% of 544 laboratories responding to the survey, only 18.7% reported using GBS NAATs for screening. Thirty-nine percent of laboratories used NAAT for antepartum screening only, 22% for intrapartum only, and 17% for both, with 21% not specifying their use context 51. Almost all (97.4%) laboratories reporting GBS NAAT use were hospital or clinic-based, compared with 12.6% use in commercial or private laboratories. In addition, 82% of laboratories using NAAT for antepartum GBS screening reported using an enrichment step before the assay was performed "
As you can see mits, as of 4 yrs ago less than 20% of the responding laboratories were using NAAT (a/k/a a PCR based test) for GBS screening. So the belief that PCR diagnostics controlled the market and shut out NNLX from GBS screening is unfounded.
"A recent CDC survey from 10 states participating in the Active Bacterial Core Surveillance demonstrated that, although use of NAAT-based assays for GBS screening has increased since the last perinatal guidelines were published in 2010, reported use overall remained low in 2016. With more than 93% of 544 laboratories responding to the survey, only 18.7% reported using GBS NAATs for screening. Thirty-nine percent of laboratories used NAAT for antepartum screening only, 22% for intrapartum only, and 17% for both, with 21% not specifying their use context 51. Almost all (97.4%) laboratories reporting GBS NAAT use were hospital or clinic-based, compared with 12.6% use in commercial or private laboratories. In addition, 82% of laboratories using NAAT for antepartum GBS screening reported using an enrichment step before the assay was performed "
As you can see mits, as of 4 yrs ago less than 20% of the responding laboratories were using NAAT (a/k/a a PCR based test) for GBS screening. So the belief that PCR diagnostics controlled the market and shut out NNLX from GBS screening is unfounded.
(4)
(0)